Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym.Unit - manually
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
(-)Biological Unit 3
(-)Biological Unit 4
collapse expand < >
Image Asym.Unit - manually
Asym.Unit - manually  (Jmol Viewer)
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)
Image Biological Unit 3
Biological Unit 3  (Jmol Viewer)
Image Biological Unit 4
Biological Unit 4  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
 
Authors :  T. Huyton, J. G. Zhang, N. A. Nicola, T. P. J. Garrett
Date :  07 Jun 07  (Deposition) - 31 Jul 07  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  4.00
Chains :  Asym. Unit :  A,B,C,D,E#,F#,G#,H#,I#,J#,K#,L#,M#,N#,O#,P#,Q#,R#,S#
Biol. Unit 1:  A,B  (1x)
Biol. Unit 2:  C,D  (1x)
Biol. Unit 3:  A,B,C,D  (2x)
Biol. Unit 4:  A,B,C,D  (2x)
#:   chains that contain no standard or modified protein/DNA/RNA residue)
 
Keywords :  Cytokine Cell Surface Receptor Complex Lifr Lif, Cytokine Receptor- Cytokine Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  T. Huyton, J. G. Zhang, C. S. Luo, M. Z. Lou, D. J. Hilton, N. A. Nicola, T. P. Garrett
An Unusual Cytokine:Ig-Domain Interaction Revealed In The Crystal Structure Of Leukemia Inhibitory Factor (Lif) In Complex With The Lif Receptor.
Proc. Natl. Acad. Sci. Usa V. 104 12737 2007
PubMed-ID: 17652170  |  Reference-DOI: 10.1073/PNAS.0705577104

(-) Compounds

Molecule 1 - LEUKEMIA INHIBITORY FACTOR RECEPTOR
    ChainsA, C
    EngineeredYES
    Expression SystemCRICETULUS GRISEUS
    Expression System CommonCHINESE HAMSTER
    Expression System PlasmidPCHO1/MLIFR
    Expression System StrainCHO-K1
    Expression System Taxid10029
    GeneLIFR
    Organism CommonHOUSE MOUSE
    Organism ScientificMUS MUSCULUS
    Organism Taxid10090
    SynonymLIF RECEPTOR, LIF-R, D-FACTOR/LIF RECEPTOR, CD118 ANTIGEN
 
Molecule 2 - LEUKEMIA INHIBITORY FACTOR
    ChainsB, D
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    GeneLIF, HILDA
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymLIF, DIFFERENTIATION-STIMULATING FACTOR, D FACTOR, MELANOMA- DERIVED LPL INHIBITOR, MLPLI, EMFILERMIN

 Structural Features

(-) Chains, Units

  12345678910111213141516171819
Asymmetric Unit ABCDE#F#G#H#I#J#K#L#M#N#O#P#Q#R#S#
Biological Unit 1 (1x)AB                 
Biological Unit 2 (1x)  CD               
Biological Unit 3 (2x)ABCD               
Biological Unit 4 (2x)ABCD               
#:   chains that contain no standard or modified protein/DNA/RNA residue)
 

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 45)

Asymmetric Unit (3, 45)
No.NameCountTypeFull Name
1FUC7Ligand/IonALPHA-L-FUCOSE
2MAN5Ligand/IonALPHA-D-MANNOSE
3NAG33Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 1 (1, 1)
No.NameCountTypeFull Name
1FUC-1Ligand/IonALPHA-L-FUCOSE
2MAN-1Ligand/IonALPHA-D-MANNOSE
3NAG1Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 2 (1, 2)
No.NameCountTypeFull Name
1FUC-1Ligand/IonALPHA-L-FUCOSE
2MAN-1Ligand/IonALPHA-D-MANNOSE
3NAG2Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 3 (1, 6)
No.NameCountTypeFull Name
1FUC-1Ligand/IonALPHA-L-FUCOSE
2MAN-1Ligand/IonALPHA-D-MANNOSE
3NAG6Ligand/IonN-ACETYL-D-GLUCOSAMINE
Biological Unit 4 (1, 6)
No.NameCountTypeFull Name
1FUC-1Ligand/IonALPHA-L-FUCOSE
2MAN-1Ligand/IonALPHA-D-MANNOSE
3NAG6Ligand/IonN-ACETYL-D-GLUCOSAMINE

(-) Sites  (45, 45)

Asymmetric Unit (45, 45)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREASN A:121 , FUC E:102 , NAG E:103BINDING SITE FOR RESIDUE NAG E 101
02AC2SOFTWAREHIS A:175 , NAG E:101BINDING SITE FOR RESIDUE FUC E 102
03AC3SOFTWARENAG E:101BINDING SITE FOR RESIDUE NAG E 103
04AC4SOFTWARELEU A:106 , ASN A:156 , NAG F:203BINDING SITE FOR RESIDUE NAG F 201
05AC5SOFTWARELYS D:136 , NAG F:201BINDING SITE FOR RESIDUE NAG F 203
06AC6SOFTWARELEU A:193 , ASN A:195 , NAG G:302BINDING SITE FOR RESIDUE NAG G 301
07AC7SOFTWARENAG G:301BINDING SITE FOR RESIDUE NAG G 302
08AC8SOFTWAREASN A:218 , FUC H:402 , NAG H:403BINDING SITE FOR RESIDUE NAG H 401
09AC9SOFTWARENAG H:401BINDING SITE FOR RESIDUE FUC H 402
10AD1SOFTWARENAG H:401BINDING SITE FOR RESIDUE NAG H 403
11AD2SOFTWAREASN A:342 , FUC I:502 , NAG I:503BINDING SITE FOR RESIDUE NAG I 501
12AD3SOFTWAREMAN J:703BINDING SITE FOR RESIDUE MAN J 704
13AD4SOFTWAREASN A:397 , SER A:398 , THR A:399 , ALA B:117 , FUC K:802 , NAG K:803BINDING SITE FOR RESIDUE NAG K 801
14BC3SOFTWAREASN A:342 , ASP C:35 , NAG I:501BINDING SITE FOR RESIDUE FUC I 502
15BC4SOFTWARENAG I:501BINDING SITE FOR RESIDUE NAG I 503
16BC5SOFTWAREASN A:359BINDING SITE FOR RESIDUE NAG A 601
17BC6SOFTWAREGLU A:356 , ASN A:378 , GLU A:381 , NAG J:702BINDING SITE FOR RESIDUE NAG J 701
18BC7SOFTWARENAG J:701 , MAN J:703BINDING SITE FOR RESIDUE NAG J 702
19BC8SOFTWARENAG J:702 , MAN J:704BINDING SITE FOR RESIDUE MAN J 703
20CC2SOFTWARENAG K:801BINDING SITE FOR RESIDUE FUC K 802
21CC3SOFTWAREASP A:449 , GLY B:35 , SER B:36 , LYS B:114 , NAG K:801 , MAN K:804BINDING SITE FOR RESIDUE NAG K 803
22CC4SOFTWARENAG K:803BINDING SITE FOR RESIDUE MAN K 804
23CC5SOFTWAREASN A:410 , GLU A:440 , NAG L:902BINDING SITE FOR RESIDUE NAG L 901
24CC6SOFTWARENAG L:901BINDING SITE FOR RESIDUE NAG L 902
25CC7SOFTWAREASN C:121 , THR C:144 , NAG M:102BINDING SITE FOR RESIDUE NAG M 101
26CC8SOFTWARENAG M:101BINDING SITE FOR RESIDUE NAG M 102
27CC9SOFTWAREALA C:98 , SER C:104 , ASN C:156BINDING SITE FOR RESIDUE NAG C 501
28DC1SOFTWAREASN C:195BINDING SITE FOR RESIDUE NAG C 601
29DC2SOFTWAREASN C:218 , FUC N:402 , NAG N:403BINDING SITE FOR RESIDUE NAG N 401
30DC3SOFTWARENAG N:401 , NAG N:403BINDING SITE FOR RESIDUE FUC N 402
31DC4SOFTWARENAG N:401 , FUC N:402BINDING SITE FOR RESIDUE NAG N 403
32DC5SOFTWAREASN C:342 , FUC O:502 , NAG O:503BINDING SITE FOR RESIDUE NAG O 501
33DC6SOFTWARENAG O:501BINDING SITE FOR RESIDUE FUC O 502
34DC7SOFTWARENAG O:501BINDING SITE FOR RESIDUE NAG O 503
35DC8SOFTWAREASN C:359 , NAG P:603BINDING SITE FOR RESIDUE NAG P 601
36DC9SOFTWARENAG P:601BINDING SITE FOR RESIDUE NAG P 603
37EC1SOFTWAREASN C:378 , THR C:380 , GLU C:381 , NAG Q:703BINDING SITE FOR RESIDUE NAG Q 701
38EC2SOFTWARENAG Q:701BINDING SITE FOR RESIDUE NAG Q 703
39EC3SOFTWAREASN C:397 , THR C:399 , FUC R:802 , NAG R:803BINDING SITE FOR RESIDUE NAG R 801
40EC4SOFTWARENAG R:801BINDING SITE FOR RESIDUE FUC R 802
41EC5SOFTWAREGLN D:32 , SER D:36 , NAG R:801 , MAN R:804BINDING SITE FOR RESIDUE NAG R 803
42EC6SOFTWAREGLY D:35 , NAG R:803 , MAN R:805BINDING SITE FOR RESIDUE MAN R 804
43EC7SOFTWAREMAN R:804BINDING SITE FOR RESIDUE MAN R 805
44EC8SOFTWAREGLY C:354 , ASN C:410 , GLU C:440 , NAG S:902BINDING SITE FOR RESIDUE NAG S 901
45EC9SOFTWAREHIS C:352 , NAG S:901BINDING SITE FOR RESIDUE NAG S 902

(-) SS Bonds  (16, 16)

Asymmetric Unit
No.Residues
1A:10 -A:20
2A:37 -A:45
3A:165 -A:222
4A:293 -A:303
5A:418 -A:463
6B:12 -B:134
7B:18 -B:131
8B:60 -B:163
9C:10 -C:20
10C:37 -C:45
11C:165 -C:222
12C:293 -C:303
13C:418 -C:463
14D:12 -D:134
15D:18 -D:131
16D:60 -D:163

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1Phe A:207 -Pro A:208
2Glu B:50 -Pro B:51
3Phe C:207 -Pro C:208
4Glu D:50 -Pro D:51

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (0, 0)

(no "SAP(SNP)/Variant" information available for 2Q7N)

(-) PROSITE Motifs  (2, 6)

Asymmetric Unit (2, 6)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LIF_OSMPS00590 LIF / OSM family signature.LIF_HUMAN173-192
 
  2B:151-170
D:151-170
2FN3PS50853 Fibronectin type-III domain profile.LIFR_MOUSE330-429
 
430-529
 
533-624
719-828
  4A:287-386
C:287-386
A:387-486
C:387-486
-
-
Biological Unit 1 (2, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LIF_OSMPS00590 LIF / OSM family signature.LIF_HUMAN173-192
 
  1B:151-170
-
2FN3PS50853 Fibronectin type-III domain profile.LIFR_MOUSE330-429
 
430-529
 
533-624
719-828
  2A:287-386
-
A:387-486
-
-
-
Biological Unit 2 (2, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LIF_OSMPS00590 LIF / OSM family signature.LIF_HUMAN173-192
 
  1-
D:151-170
2FN3PS50853 Fibronectin type-III domain profile.LIFR_MOUSE330-429
 
430-529
 
533-624
719-828
  2-
C:287-386
-
C:387-486
-
-
Biological Unit 3 (2, 12)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LIF_OSMPS00590 LIF / OSM family signature.LIF_HUMAN173-192
 
  4B:151-170
D:151-170
2FN3PS50853 Fibronectin type-III domain profile.LIFR_MOUSE330-429
 
430-529
 
533-624
719-828
  8A:287-386
C:287-386
A:387-486
C:387-486
-
-
Biological Unit 4 (2, 12)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1LIF_OSMPS00590 LIF / OSM family signature.LIF_HUMAN173-192
 
  4B:151-170
D:151-170
2FN3PS50853 Fibronectin type-III domain profile.LIFR_MOUSE330-429
 
430-529
 
533-624
719-828
  8A:287-386
C:287-386
A:387-486
C:387-486
-
-

(-) Exons   (2, 4)

Asymmetric Unit (2, 4)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002490751aENSE00001551728chr22:30642840-30642666175LIF_HUMAN1-770--
1.2ENST000002490752ENSE00000879785chr22:30640922-30640744179LIF_HUMAN7-66602B:1-44
D:1-44
44
44
1.3bENST000002490753bENSE00001215846chr22:30640050-306364363615LIF_HUMAN67-2021362B:45-180
D:45-180
136
136

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:480
 aligned with LIFR_MOUSE | P42703 from UniProtKB/Swiss-Prot  Length:1092

    Alignment length:480
                                    59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529
           LIFR_MOUSE    50 DLKCTTNNMRVWDCTWPAPLGVSPGTVKDICIKDRFHSCHPLETTNVKIPALSPGDHEVTINYLNGFQSKFTLNEKDVSLIPETPEILDLSADFFTSSLLLKWNDRGSALPHPSNATWEIKVLQNPRTEPVALVLLNTMLSGKDTVQHWNWTSDLPLQCATHSVSIRWHIDSPHFSGYKEWSDWSPLKNISWIRNTETNVFPQDKVVLAGSNMTICCMSPTKVLSGQIGNTLRPLIHLYGQTVAIHILNIPVSENSGTNIIFITDDDVYGTVVFAGYPPDVPQKLSCETHDLKEIICSWNPGRITGLVGPRNTEYTLFESISGKSAVFHRIEGLTNETYRLGVQMHPGQEIHNFTLTGRNPLGQAQSAVVINVTERVAPHDPTSLKVKDINSTVVTFSWYLPGNFTKINLLCQIEICKANSKKEVRNATIRGAEDSTYHVAVDKLNPYTAYTFRVRCSSKTFWKWSRWSDEKRHLTTEAT 529
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ....ee....eeeee...........eeeeeee...eeeee....eeeee......eeeeeee....eeeeee.....ee......eee..ee....eeeeee..hhhhh...eeeeeeee............ee..ee........eeeee..........eeeeeeee.................ee..........ee....eee.....eeee.....eeeeee..ee...ee.....eeee...........eeeeeee...eeeeeeeee.........eee.....eeeeee..............eeeeee.....eeeee.........eeeeee........eeeeeeee..eeeeeeee.hhhhh......eeeeeee.....eeeeeeeeee....eeeeeeee.......eeeeeeee..eeeeeeeee............eeeee..................... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FN3  PDB: A:287-386 UniProt: 330-429                                                                FN3  PDB: A:387-486 UniProt: 430-529                                                                 PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 2q7n A   7 DLKCTTNNMRVWDCTWPAPLGVSPGTVKDICIKDRFHSCHPLETTNVKIPALSPGDHEVTINYLNGFQSKFTLNEKDVSLIPETPEILDLSADFFTSSLLLKWNDRGSALPHPSNATWEIKVLQNPRTEPVALVLLNTMLSGKDTVQHWNWTSDLPLQCATHSVSIRWHIDSPHFSGYKEWSDWSPLKNISWIRNTETNVFPQDKVVLAGSNMTICCMSPTKVLSGQIGNTLRPLIHLYGQTVAIHILNIPVSENSGTNIIFITDDDVYGTVVFAGYPPDVPQKLSCETHDLKEIICSWNPGRITGLVGPRNTEYTLFESISGKSAVFHRIEGLTNETYRLGVQMHPGQEIHNFTLTGRNPLGQAQSAVVINVTERVAPHDPTSLKVKDINSTVVTFSWYLPGNFTKINLLCQIEICKANSKKEVRNATIRGAEDSTYHVAVDKLNPYTAYTFRVRCSSKTFWKWSRWSDEKRHLTTEAT 486
                                    16        26        36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486

Chain B from PDB  Type:PROTEIN  Length:180
 aligned with LIF_HUMAN | P15018 from UniProtKB/Swiss-Prot  Length:202

    Alignment length:180
                                    32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202
            LIF_HUMAN    23 SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF 202
               SCOP domains -----------d2q7nb1 B:12-180 Leukemia inhibitory factor (LIF)                                                                                                                         SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author .....................hhhhhhhhhhhhhhhhhhhhhhhhhhh......hhhhhh..............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhh....................hhhhhhhhhhhhhhhhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------LIF_OSM             ---------- PROSITE
               Transcript 1 Exon 1.2  PDB: B:1-44 UniProt: 7-66         Exon 1.3b  PDB: B:45-180 UniProt: 67-202                                                                                                 Transcript 1
                 2q7n B   1 SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF 180
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180

Chain C from PDB  Type:PROTEIN  Length:480
 aligned with LIFR_MOUSE | P42703 from UniProtKB/Swiss-Prot  Length:1092

    Alignment length:480
                                    59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529
           LIFR_MOUSE    50 DLKCTTNNMRVWDCTWPAPLGVSPGTVKDICIKDRFHSCHPLETTNVKIPALSPGDHEVTINYLNGFQSKFTLNEKDVSLIPETPEILDLSADFFTSSLLLKWNDRGSALPHPSNATWEIKVLQNPRTEPVALVLLNTMLSGKDTVQHWNWTSDLPLQCATHSVSIRWHIDSPHFSGYKEWSDWSPLKNISWIRNTETNVFPQDKVVLAGSNMTICCMSPTKVLSGQIGNTLRPLIHLYGQTVAIHILNIPVSENSGTNIIFITDDDVYGTVVFAGYPPDVPQKLSCETHDLKEIICSWNPGRITGLVGPRNTEYTLFESISGKSAVFHRIEGLTNETYRLGVQMHPGQEIHNFTLTGRNPLGQAQSAVVINVTERVAPHDPTSLKVKDINSTVVTFSWYLPGNFTKINLLCQIEICKANSKKEVRNATIRGAEDSTYHVAVDKLNPYTAYTFRVRCSSKTFWKWSRWSDEKRHLTTEAT 529
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn3-2q7nC01 C:386-475                                                                     ----------- Pfam domains (1)
           Pfam domains (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn3-2q7nC02 C:386-475                                                                     ----------- Pfam domains (2)
         Sec.struct. author ..eeee....eeeee...........eeeeee.....eeee....eeeee......eeeeeee.......eeehhh.eee........eee......eeeee...hhhhh....eeeeeeeee........eeeeeee...........eee..........eeeeeeee.......ee....................ee....eee....eeeee.......eeee..eee..........eeee..........eeeeee....eeeeeeeee.........eee.....eeeee.........hhhhh...eeee.....eee..............eee......eeeeeeeeee..eeeeeeeeee..........eeeeeee.....eeeeeeeeee....eeeeeeeee......eeeeeeee..eeeeeeeee........eeeeeeeee............eee...... Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FN3  PDB: C:287-386 UniProt: 330-429                                                                FN3  PDB: C:387-486 UniProt: 430-529                                                                 PROSITE
                 Transcript ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Transcript
                 2q7n C   7 DLKCTTNNMRVWDCTWPAPLGVSPGTVKDICIKDRFHSCHPLETTNVKIPALSPGDHEVTINYLNGFQSKFTLNEKDVSLIPETPEILDLSADFFTSSLLLKWNDRGSALPHPSNATWEIKVLQNPRTEPVALVLLNTMLSGKDTVQHWNWTSDLPLQCATHSVSIRWHIDSPHFSGYKEWSDWSPLKNISWIRNTETNVFPQDKVVLAGSNMTICCMSPTKVLSGQIGNTLRPLIHLYGQTVAIHILNIPVSENSGTNIIFITDDDVYGTVVFAGYPPDVPQKLSCETHDLKEIICSWNPGRITGLVGPRNTEYTLFESISGKSAVFHRIEGLTNETYRLGVQMHPGQEIHNFTLTGRNPLGQAQSAVVINVTERVAPHDPTSLKVKDINSTVVTFSWYLPGNFTKINLLCQIEICKANSKKEVRNATIRGAEDSTYHVAVDKLNPYTAYTFRVRCSSKTFWKWSRWSDEKRHLTTEAT 486
                                    16        26        36        46        56        66        76        86        96       106       116       126       136       146       156       166       176       186       196       206       216       226       236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456       466       476       486

Chain D from PDB  Type:PROTEIN  Length:180
 aligned with LIF_HUMAN | P15018 from UniProtKB/Swiss-Prot  Length:202

    Alignment length:180
                                    32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202
            LIF_HUMAN    23 SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF 202
               SCOP domains -----------d2q7nd1 D:12-180 Leukemia inhibitory factor (LIF)                                                                                                                         SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
           Pfam domains (1) --------------------LIF_OSM-2q7nD01 D:21-180                                                                                                                                         Pfam domains (1)
           Pfam domains (2) --------------------LIF_OSM-2q7nD02 D:21-180                                                                                                                                         Pfam domains (2)
         Sec.struct. author .....................hhhhhhhhhhhhhhhhhhhhhhhhhhhh.........................hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhh...................hhhhhhhhhhhhhhhhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------LIF_OSM             ---------- PROSITE
               Transcript 1 Exon 1.2  PDB: D:1-44 UniProt: 7-66         Exon 1.3b  PDB: D:45-180 UniProt: 67-202                                                                                                 Transcript 1
                 2q7n D   1 SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF 180
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2Q7N)

(-) Pfam Domains  (2, 4)

Asymmetric Unit
(-)
Clan: E-set (290)
(-)
Family: fn3 (66)
2afn3-2q7nC01C:386-475
2bfn3-2q7nC02C:386-475

(-) Gene Ontology  (72, 77)

Asymmetric Unit(hide GO term definitions)
Chain A,C   (LIFR_MOUSE | P42703)
molecular function
    GO:0004897    ciliary neurotrophic factor receptor activity    Combining with ciliary neurotrophic factor (CNTF) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005127    ciliary neurotrophic factor receptor binding    Interacting selectively and non-covalently with the ciliary neurotrophic factor receptor.
    GO:0019955    cytokine binding    Interacting selectively and non-covalently with a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity.
    GO:0004896    cytokine receptor activity    Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0019838    growth factor binding    Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
    GO:0004923    leukemia inhibitory factor receptor activity    Combining with leukemia inhibitory factor (LIF) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0004924    oncostatin-M receptor activity    Combining with oncostatin-M and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0046982    protein heterodimerization activity    Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
biological process
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0070120    ciliary neurotrophic factor-mediated signaling pathway    A series of molecular signals initiated by the binding of a ciliary neurotrophic factor (CNTF) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0019221    cytokine-mediated signaling pathway    A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0048861    leukemia inhibitory factor signaling pathway    Any series of molecular signals initiated by the binding of leukemia inhibitory factor to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0010656    negative regulation of muscle cell apoptotic process    Any process that decreases the rate or frequency of muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a muscle cell and result in its death.
    GO:0048812    neuron projection morphogenesis    The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites.
    GO:0038165    oncostatin-M-mediated signaling pathway    A series of molecular signals initiated by the binding of oncostatin-M (OSM) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. OSM can signal via at least two different receptors (a specific receptor and a LIF receptor) to activate different downstream signal transduction pathways.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0034097    response to cytokine    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
    GO:0014070    response to organic cyclic compound    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
cellular component
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

Chain B,D   (LIF_HUMAN | P15018)
molecular function
    GO:0005125    cytokine activity    Functions to control the survival, growth, differentiation and effector function of tissues and cells.
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0005146    leukemia inhibitory factor receptor binding    Interacting selectively and non-covalently with the leukemia inhibitory factor receptor.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0001135    transcription factor activity, RNA polymerase II transcription factor recruiting    The function of binding to an RNA polymerase II (RNAP II) transcription factor and recruiting it to the transcription machinery complex in order to modulate transcription by RNAP II.
biological process
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0048708    astrocyte differentiation    The process in which a relatively unspecialized cell acquires the specialized features of an astrocyte. An astrocyte is the most abundant type of glial cell. Astrocytes provide support for neurons and regulate the environment in which they function.
    GO:0001974    blood vessel remodeling    The reorganization or renovation of existing blood vessels.
    GO:0046697    decidualization    The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta.
    GO:0007566    embryo implantation    Attachment of the blastocyst to the uterine lining.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0048861    leukemia inhibitory factor signaling pathway    Any series of molecular signals initiated by the binding of leukemia inhibitory factor to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0048286    lung alveolus development    The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
    GO:0030324    lung development    The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
    GO:0060463    lung lobe morphogenesis    The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
    GO:0060426    lung vasculature development    The biological process whose specific outcome is the progression of a lung vasculature from an initial condition to its mature state. This process begins with the formation of the lung vasculature and ends with the mature structure. The lung vasculature is composed of the tubule structures that carry blood or lymph in the lungs.
    GO:0060135    maternal process involved in female pregnancy    A reproductive process occurring in the mother that allows an embryo or fetus to develop within it.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0048644    muscle organ morphogenesis    The process in which the anatomical structures of muscle are generated and organized.
    GO:0070373    negative regulation of ERK1 and ERK2 cascade    Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0016525    negative regulation of angiogenesis    Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
    GO:0008285    negative regulation of cell proliferation    Any process that stops, prevents or reduces the rate or extent of cell proliferation.
    GO:0046888    negative regulation of hormone secretion    Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a hormone from a cell.
    GO:0045835    negative regulation of meiotic nuclear division    Any process that stops, prevents, or reduces the frequency, rate or extent of meiosis.
    GO:0048666    neuron development    The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0048711    positive regulation of astrocyte differentiation    Any process that activates or increases the frequency, rate or extent of astrocyte differentiation.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0051461    positive regulation of corticotropin secretion    Any process that activates or increases the frequency, rate or extent of the regulated release of corticotropin hormone from a cell.
    GO:0010628    positive regulation of gene expression    Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:1901676    positive regulation of histone H3-K27 acetylation    Any process that activates or increases the frequency, rate or extent of histone H3-K27 acetylation.
    GO:0045651    positive regulation of macrophage differentiation    Any process that activates or increases the frequency, rate or extent of macrophage differentiation.
    GO:0072108    positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis    Any process that increases the rate, frequency or extent of the transition where a mesenchymal cell establishes apical/basolateral polarity, forms intercellular adhesive junctions, synthesizes basement membrane components and becomes an epithelial cell that will contribute to the shaping of the metanephros.
    GO:0010976    positive regulation of neuron projection development    Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
    GO:0033138    positive regulation of peptidyl-serine phosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
    GO:0033141    positive regulation of peptidyl-serine phosphorylation of STAT protein    Any process that activates or increases the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
    GO:0050731    positive regulation of peptidyl-tyrosine phosphorylation    Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
    GO:1900182    positive regulation of protein localization to nucleus    Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:1903025    regulation of RNA polymerase II regulatory region sequence-specific DNA binding    Any process that modulates the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
    GO:0045595    regulation of cell differentiation    Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
    GO:0072307    regulation of metanephric nephron tubule epithelial cell differentiation    Any process that modulates the frequency, rate or extent of metanephric nephron tubule epithelial cell differentiation.
    GO:0060041    retina development in camera-type eye    The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
    GO:0060708    spongiotrophoblast differentiation    The process in which a relatively unspecialized cell of the ectoplacental cone acquires specialized features of a spongiotrophoblast of the placenta. A spongiotrophoblast cell is a basophilic cell.
    GO:0048863    stem cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
    GO:0019827    stem cell population maintenance    The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
    GO:0060290    transdifferentiation    The conversion of a differentiated cell of one fate into a differentiated cell of another fate without first undergoing cell division or reversion to a more primitive or stem cell-like fate.
    GO:0060707    trophoblast giant cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a trophoblast giant cell of the placenta. Trophoblast giant cells are the cell of the placenta that line the maternal decidua.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MAN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    AD1  [ RasMol ]  +environment [ RasMol ]
    AD2  [ RasMol ]  +environment [ RasMol ]
    AD3  [ RasMol ]  +environment [ RasMol ]
    AD4  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
    CC3  [ RasMol ]  +environment [ RasMol ]
    CC4  [ RasMol ]  +environment [ RasMol ]
    CC5  [ RasMol ]  +environment [ RasMol ]
    CC6  [ RasMol ]  +environment [ RasMol ]
    CC7  [ RasMol ]  +environment [ RasMol ]
    CC8  [ RasMol ]  +environment [ RasMol ]
    CC9  [ RasMol ]  +environment [ RasMol ]
    DC1  [ RasMol ]  +environment [ RasMol ]
    DC2  [ RasMol ]  +environment [ RasMol ]
    DC3  [ RasMol ]  +environment [ RasMol ]
    DC4  [ RasMol ]  +environment [ RasMol ]
    DC5  [ RasMol ]  +environment [ RasMol ]
    DC6  [ RasMol ]  +environment [ RasMol ]
    DC7  [ RasMol ]  +environment [ RasMol ]
    DC8  [ RasMol ]  +environment [ RasMol ]
    DC9  [ RasMol ]  +environment [ RasMol ]
    EC1  [ RasMol ]  +environment [ RasMol ]
    EC2  [ RasMol ]  +environment [ RasMol ]
    EC3  [ RasMol ]  +environment [ RasMol ]
    EC4  [ RasMol ]  +environment [ RasMol ]
    EC5  [ RasMol ]  +environment [ RasMol ]
    EC6  [ RasMol ]  +environment [ RasMol ]
    EC7  [ RasMol ]  +environment [ RasMol ]
    EC8  [ RasMol ]  +environment [ RasMol ]
    EC9  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Glu B:50 - Pro B:51   [ RasMol ]  
    Glu D:50 - Pro D:51   [ RasMol ]  
    Phe A:207 - Pro A:208   [ RasMol ]  
    Phe C:207 - Pro C:208   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]
    Biological Unit 3  [ Jena3D ]
    Biological Unit 4  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2q7n
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  LIFR_MOUSE | P42703
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  LIF_HUMAN | P15018
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  LIFR_MOUSE | P42703
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  LIF_HUMAN | P15018
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        LIF_HUMAN | P150181emr 1pvh

(-) Related Entries Specified in the PDB File

1pvh LIF IN COMPLEX WITH GP130